CXI Advisors’s Elevance Health ELV Stock Holding History

CXI Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$4K	Buy	+13	New	+$3.58K	0.01%	167

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

CXI Advisors's ELV Position: Q4 2019 in Review

CXI Advisors opened a new position in Elevance Health (ELV) in Q4 2019: 13 shares worth $4K. The stake represents 0.01% of the portfolio and ranks #167 among its holdings.

1,111 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

CXI Advisors held 13 shares of Elevance Health worth $4K as of Q4 2019.
Elevance Health was a new CXI Advisors position in Q4 2019.
Elevance Health made up 0.01% of CXI Advisors's portfolio in Q4 2019, its #167 holding.
1,111 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on CXI Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.